ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "fibromyalgia"

  • Abstract Number: 219 • 2019 ACR/ARP Annual Meeting

    A Fibromyalgia Assessment Screening Tool on a Multidimensional Health Assessment Questionnaire (MDHAQ) Which Does Not Include a Self-Report RADAI Painful Joint Count (RADAI), FAST3nJC, Recognizes Fibromyalgia Similarly to Other FAST3 Indices Which Include a RADAI

    Theodore Pincus1, Isabel Castrejon 2 and Joel Block 2, 1Division of Rheumatology, Rush University Medical Center, Chicago, IL, 2Rush University Medical Center, Chicago, IL

    Background/Purpose: Fibromyalgia (FM) generally is easily recognized, but a diagnosis may be difficult, particularly in patients with secondary FM who have other primary diagnoses. Criteria…
  • Abstract Number: 683 • 2019 ACR/ARP Annual Meeting

    Biologic Differences Between Type 1 and 2 Lupus

    Megan Clowse1, Jennifer Rogers 1, Amanda Eudy 1, Lisa Criscione-Schreiber 1, Jayanth Doss 1, Rebecca Sadun 1, Kai Sun 1, Micah McClain 2, Ephraim Tsalik 3, Chris Woods 2, David Pisetsky 4, Prathyusha Bachali 5, Amrie Grammer 6, Michelle Catalina 5 and Peter Lipsky 7, 1Duke University, Durham, 2Duke University & Duke Center for Applied Genomics & Precision Medicine, Durham, 3Duke University, Duke Center for Applied Genomics & Precision Medicine, Durham VA, Durham, 4Duke University, Durham VAMC, Durham, 5AMPEL BioSolutions and the RILITE Research Institute, Charlottesville, VA, 6AMPEL BioSolutions and the RILITE Research Institute, Charlottesville, 7AMPEL BioSolutions, LLC, Charlottesville, VA

    Background/Purpose: The manifestations of systemic lupus erythematosus (SLE) can be divided into categories according to a recently proposed model:  a category of classic active autoimmune-driven…
  • Abstract Number: 220 • 2019 ACR/ARP Annual Meeting

    A Positive Response to Nonpharmacological Therapies in Patients with Fibromyalgia

    Raveendhara Bannuru1, Michelle Park 2, Lori Lyn Price 3 and Chenchen Wang 4, 1Tufts Medical Center, Boston, MA, 2Tufts University School of Medicine, Boston, MA, 3Tufts Medical Center, Tufts University, Boston, MA, 4Tufts Medical Center, Boston

    Background/Purpose: Identifying the factors associated with response to nonpharmacological therapies in patients with fibromyalgia will help personalize treatments and provide information to improve the design…
  • Abstract Number: 827 • 2019 ACR/ARP Annual Meeting

    A Phase 3 Randomized, Double-Blind, Placebo-Controlled Trial of Bedtime Sublingual Cyclobenzaprine (TNX-102 SL) for the Treatment of Fibromyalgia (FM): Evidence for a Broad Spectrum of Activity on the FM Syndrome

    Gregory Sullivan1, R. Michael Gendreau 2, Judith Gendreau 3, Ashild Peters 4, Perry Peters 5 and Seth Lederman 6, 1Tonix Pharmaceuticals Inc., New York, 2Gendreau Consulting, Poway, CA, 3Tonix Pharmaceuticals Inc, Poway, CA, 4Tonix Pharmaceuticals Inc., San Diego, CA, 5Tonix Pharmaceuticals Inc, San Diego, CA, 6Tonix Pharmaceuticals Inc, New York, NY

    Background/Purpose: Fibromyalgia (FM) is characterized by chronic widespread pain, unrefreshing sleep, fatigue, and cognitive complaints.  TNX-102 SL* is a sublingual (SL) formulation of cyclobenzaprine (CBP)…
  • Abstract Number: L19 • 2018 ACR/ARHP Annual Meeting

    Transcutaneous Electrical Nerve Stimulation (TENS) Reduces Pain and Fatigue and Improves Disease Impact in Women with Fibromyalgia: A Randomized Controlled Trial

    Leslie Crofford1, Dana Daily2, Carol Vance3, Ruth Chimenti2, Ericka Merriwether4, Miriam Bridget Zimmerman5, Jonathan Williams6, Meena Golchha6, Li Alemo Munters7, Katharine Geasland3, Barbara Rakel8 and Kathleen Sluka2, 1Division of Rheumatology and Immunology, Vanderbilt University Medical Center, Nashville, TN, 2Physical Therapy, University of Iowa, Iowa City, IA, 3University of Iowa, Iowa City, IA, 4Physical Therapy, New York University, New York, NY, 5Public Health, University of Iowa, Iowa City, IA, 6Vanderbilt University Medical Center, Nashville, TN, 7Karolinska Institutet, Stockholm, Sweden, 8Nursing, University of Iowa, Iowa City, IA

    Background/Purpose: Fibromyalgia (FM) is a chronic pain condition associated with pain and fatigue, especially during physical activity. Treatments designed to modulate central pain pathways to…
  • Abstract Number: 249 • 2018 ACR/ARHP Annual Meeting

    Patients with Fibromyalgia May be Fearful of Developing Dementia Despite Lack of Concrete Evidence of Cognitive Decline

    Robert S. Katz1 and Frank Leavitt2, 1Rheumatology, Rush University Medical Center, Chicago, IL, 2Rush University Medical Center, Chicago, IL

    Background/Purpose: Core features of cognitive dysfunction in fibromyalgia are memory loss and disturbance in mental clarity. The present study examines if disturbance in mental clarity,…
  • Abstract Number: 255 • 2018 ACR/ARHP Annual Meeting

    Interpretation of Proverbs Compared with the Mental Clutter Scale in Fibromyalgia Patients Demonstrates Intact Intellectual Ability Despite the Symptoms of Fibrofog

    Robert S. Katz1 and Lauren Kwan2, 1Rush University Medical Center, Chicago, IL, 2Rheumatology Associates S.C., Chicago, IL

    Background/Purpose: Fibromyalgia patients frequently have cognitive dysfunction (fibrofog). We compared cognitive ability using an interpretation of proverbs with reported poor mental clarity and other fibrofog…
  • Abstract Number: 258 • 2018 ACR/ARHP Annual Meeting

    Association of Sudoscan Values with Disease Duration in Female Patients with Fibromyalgia

    Kyung Min Ko and Su-Jin Moon, Bucheon St. Mary's Hospital, Division of rheumatology, Department of Internal Medicine, College of Medicine, The Catholic University of Korea, Bucheon, Korea, Republic of (South)

    Background/Purpose: Fibromyalgia is characterized by chronic widespread pain. The patients with fibromyalgia complain of symptoms such as fatigue, sleep disturbance and intermittent palpitation, suggesting the…
  • Abstract Number: 259 • 2018 ACR/ARHP Annual Meeting

    Prevalence of Attention Deficit Hyperactivity Disorder Among Patients with Fibromyalgia

    Sebastian Moyano1, Waleska Berrios2, Ignacio Javier Gandino3, Angel Golimstok4, Javier Rosa5 and Enrique R Soriano6, 1Rheumatology Unit, Internal Medicine Service, Hospital Italiano de Buenos Aires, Instituto Universitario Hospital Italiano de Buenos Aires, and Fundacion PM Catoggio, Buenos Aires, Argentina, 2Memory and Behavior Disorders Unit - Neurology Department, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina, 3Rheumatology Unit, Internal Medicine Service, Hospital Italiano de Buenos Aires, Instituto Universitario Hospital Italiano de Buenos Aires, and Fundacion PM Catoggio, Argentina., Buenos Aires, Argentina, 4Memory and Behavior Disorders Unit - Neurology Department, Hospital Italiano, Buenos Aires, Argentina, 5Rheumatology Unit, Internal Medicine Service, Hospital Italiano de Buenos Aires, Capital Federal, Argentina, 6Rheumatology Unit, Internal Medicine Service. Hospital Italiano Buenos Aires. Argentina, Buenos Aires, Argentina

    Background/Purpose: Chronic diseases involve cognitive aspects. Attention deficit hyperactivity disorder (ADHD) is a chronic condition, marked by persistent inattention, impaired concentration, hyperactivity, impulsivity, emotional lability,…
  • Abstract Number: 261 • 2018 ACR/ARHP Annual Meeting

    Mindfulness Is Associated with Sleep Quality Among Patients with Fibromyalgia

    Michelle Park1, Yuan Zhang2, Lori Lyn Price3,4, Raveendhara R. Bannuru1 and Chenchen Wang1, 1Division of Rheumatology, Center for Complementary and Integrative Medicine, Tufts Medical Center, Boston, MA, 2Susan and Alan Solomont School of Nursing, University of Massachusetts Lowell, Lowell, MA, 3Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, Boston, MA, 4Tufts Clinical and Translational Science Institute, Tufts University, Boston, MA

    Background/Purpose: Poor and disturbed sleep is an important disabling feature of fibromyalgia. Previous studies suggest higher mindfulness may be associated with better sleep quality in…
  • Abstract Number: 447 • 2018 ACR/ARHP Annual Meeting

    Discriminating between Central & Peripheral Pain Sensitization Using a Slowly Repeated Evoked Pain Protocol

    Manuel Romero1, Stephen Bruehl2, Gustavo A Reyes del Paso3 and Pablo De la Coba3, 1University Hospital of Jaén, Jaén, Spain, 2Department of Anesthesiology, Vanderbilt University, Nashville, TN, 3Department of Psychology, University of Jaén, Jaén, Spain

    Background/Purpose: In a prior study, the response of pain sensitization by fibromyalgia (FM) patients to a protocol of Slowly Repeated Evoked Pain (SREP)* was strongly…
  • Abstract Number: 747 • 2018 ACR/ARHP Annual Meeting

    The Influence of Depression on Clinical Features of Systemic Lupus Erythematosus

    Amanda M. Eudy1, Jennifer Rogers2, Lisa Criscione-Schreiber1, David Pisetsky3, Kai Sun4, Jay Doss4 and Megan E. B. Clowse1, 1Department of Medicine, Division of Rheumatology and Immunology, Duke University, Durham, NC, 2Medicine, Divison of Rheumatology, Duke University, Durham, NC, 3Department of Medicine, Duke University, Durham, NC, 4Division of Rheumatology & Immunology, Duke University, Durham, NC

    Background/Purpose: Depression occurs commonly among patients with SLE.  In this study, we used two separate scales to assess depression and determined differences in clinical characteristics…
  • Abstract Number: 839 • 2018 ACR/ARHP Annual Meeting

    Fibromyalgia Is Identified in Routine Care on Indices Derived from an MDHAQ (MultiDimensional Health Assessment Questionnaire) with Robust Agreement with 2011 Revised Fibromyalgia Criteria Questionnaire

    Juan Schmukler, Jacquelin R. Chua, Mariam Riad, Isabel Castrejón and Theodore Pincus, Division of Rheumatology, Rush University Medical Center, Chicago, IL

    Background/Purpose: Fibromyalgia (FM) generally is easily diagnosed, but maybe complex, particularly in patients who meet criteria for other rheumatic diseases. FM criteria have been revised…
  • Abstract Number: 1434 • 2018 ACR/ARHP Annual Meeting

    Patient-Proxy Agreement on Health-Related Quality of Life in Juvenile Fibromyalgia Syndrome

    Sabrina Gmuca, Audrey Urquhart and David D. Sherry, Pediatric Rheumatology, Children's Hospital of Philadelphia, Philadelphia, PA

    Background/Purpose: The administration of proxy-reported health-related quality of life (HRQoL) measures in the assessment of juvenile fibromyalgia syndrome (JFMS) is common but its added clinical…
  • Abstract Number: 241 • 2018 ACR/ARHP Annual Meeting

    Is There a Relationship between Takotsubo Cardiomyopathy and Fibromyalgia? Insights from the National Inpatient Sample Database

    Atefeh Vafa1, Setri Fugar2, Chimezie Mbachi1, Alexis K Okoh3 and John P. Case4, 1Internal Medicine, John H. Stroger, Jr. Hospital of Cook County, Chicago, IL, 2Cardiology, Rush University Medical Center, Chicago, IL, 3Cardiothoracic surgery, RWJ Barnabas health, Newark beth israel medical center, Newark, NJ, 4Internal Medicine, Chicago Medical School, North Chicago, IL

    Background/Purpose: Takotsubo cardiomyopathy (TCM) or stress cardiomyopathy is an unusual but potentially fatal type of acute cardiomyopathy characterized by transient regional left ventricular systolic dysfunction.…
  • « Previous Page
  • 1
  • …
  • 9
  • 10
  • 11
  • 12
  • 13
  • …
  • 23
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology